Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN2 | P17706 | 1/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
| ▸ | PTPN6 | P29350 | 1/20 | 0.33 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3181835 | 0.81 | PTPN2 (0.31) | PTPN2PTPN1PTPN6PTPN11POLB | |
| SCHEMBL2410644 | 0.80 | POLB (0.41) | PTPN2PTPN1PTPN6PTPN11POLB | |
| SCHEMBL2410649 | 0.80 | POLB (0.41) | PTPN2PTPN1PTPN6PTPN11POLB | |
| SCHEMBL2412622 | 0.79 | KEAP1 (0.38) | PTPN2PTPN1PTPN6PTPN11POLB | |
| SCHEMBL2412623 | 0.79 | KEAP1 (0.38) | PTPN2PTPN1PTPN6PTPN11POLB | |
| SCHEMBL3185107 | 0.78 | SSTR4 (0.32) | POLBGAAKDM4E | |
| SCHEMBL316334 | 0.76 | PTPN2 (0.35) | PTPN2PTPN1PTPN6PTPN11POLB | |
| SCHEMBL316333 | 0.76 | PTPN2 (0.35) | PTPN2PTPN1PTPN6PTPN11POLB | |
| SCHEMBL2412965 | 0.75 | KDM4E (0.36) | POLBGAAKDM4E | |
| SCHEMBL9355501 | 0.75 | DDB1 (0.43) | PTPN2PTPN1POLBGAAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7652032-B2 | 5-Thioxylopyranose compounds | LABORATOIRES FOURNIER S.A. (FR) | 2010-01-26 | — | — | US | disclosed |
| EP-2041153-B1 | NEW 5-THIOXYLOPYRANOSE DERIVATIVES | FOURNIER LAB SA (FR) | 2009-10-21 | — | — | EP | disclosed |
| US-20090118325-A1 | 5-Thioxylopyranose Compounds | LABORATOIRES FOURNIER S.A. (FR) | 2009-05-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090118325-A1 | 5-Thioxylopyranose Compounds | STS, F2, CBR1 | PTPN2 329/4885PTPN1 182/4885PTPN6 115/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.